TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT

NCT03741244 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

211

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: apatinib
DRUG: Temozolomide

Sponsor

The Second Hospital of Hebei Medical University